Tumor immune microenvironment analysis further revealed that downregulation of the Ptpn2 gene could enhance the activation of CD8+ T cells, polarization of M1 macrophages, and induction of DC maturation while promoting the release of cytokines, thus, eliciting an immunotherapeutic effect. Here, PTPN2 is linked to neoplasm.